ArticleCureus2025
Efficacy and Cost-Effectiveness of MDM2 Fluorescence In Situ Hybridization (FISH) in Morphologically Atypical Spermatic Cord Lipomas.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Enhanced FISH Image Classification via CBAM-PPM-Optimized ResNet50 for Precision Cytogenetic Diagnosis.Sensors (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSpermatic cord lipomas originate from preperitoneal adipose tissue within the internal spermatic fascia and are found in 20%-70% of all inguinal hernia repairs. Morphologically, spermatic cord lipomas may harbor some atypical features, including increased stromal cellularity with thickened fibrous bands, occasional lipoblasts, and stromal nuclear atypia or hyperchromasia, raising concern for well-differentiated liposarcoma (WDLS) versus reactive-type atypia. Fluorescence in situ hybridization (FISH) for
methodsAll cases with "specimen type" labeled as "spermatic cord lipoma" between 2018 and 2023 were retrospectively retrieved from our institutional archives. Cases were included in the study group if they had
resultsThree hundred twenty specimens labelled as spermatic cord lipoma were retrieved from our archives. Forty-three out of 320 had
conclusionOur results indicate that 2.3% of morphologically atypical specimens labeled as spermatic cord lipoma at our institution are in fact well-differentiated liposarcomas. These findings prove the efficacy of
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.